Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Viking Therapeutics Announces Initiation of Phase 1 Clinical Trial of VK0214

americanpharmaceuticalreviewSeptember 14, 2020

Tag: Viking Therapeutics , VK0214 , X-ALD

PharmaSources Customer Service